Consensus definitions for invasive fungal disease: Strengths, limitations, and revisions

被引:7
作者
Donnelly, J. Peter
机构
[1] Radboud Univ Nijmegen, Univ Med Ctr St Radboud, Dept Hematol, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Univ Med Ctr St Radboud, Nijmegen Univ Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands
关键词
definitions; invasive fungal diseases; aspergillosis; consensus;
D O I
10.1080/13693780600826707
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The European Organization for Research and Treatment of Cancer (EORTC)/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (MSG) consensus definitions for opportunistic invasive fungal infections have achieved their objective in fostering better communication between researchers but their limitations necessitated revision. In the last two years a group of experts drawn from both sides of the Atlantic have agreed a proposal for a new set of definitions that attempt to rectify omissions and problems arising from the original set whilst preserving their basic principles.
引用
收藏
页码:S285 / S288
页数:4
相关论文
共 19 条
[11]   Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: Results from the caspofungin invasive aspergillosis study [J].
Maertens, J ;
Glasmacher, A ;
Selleslag, D ;
Ngai, A ;
Ryan, D ;
Layton, M ;
Taylor, A ;
Sable, C ;
Kartsonis, N .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) :E9-E14
[12]   Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance [J].
Marr, KA ;
Balajee, SA ;
McLaughlin, L ;
Tabouret, M ;
Bentsen, C ;
Walsh, TJ .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) :641-649
[13]   Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis [J].
Millon, L ;
Piarroux, R ;
Deconinck, E ;
Bulabois, CE ;
Grenouillet, F ;
Rohrlich, P ;
Costa, JM ;
Bretagne, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5097-5101
[14]   Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes [J].
Patterson, TF ;
Kirkpatrick, WR ;
White, M ;
Hiemenz, JW ;
Wingard, JR ;
Dupont, B ;
Rinaldi, MG ;
Stevens, DA ;
Graybill, JR .
MEDICINE, 2000, 79 (04) :250-260
[15]   Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients:: a comparison with serial screening for circulating galactomannan [J].
Pazos, C ;
Pontón, J ;
Del Palacio, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :299-305
[16]  
Subirà M, 2002, HAEMATOLOGICA, V87, P528
[17]   Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia [J].
Walsh, TJ ;
Teppler, H ;
Donowitz, GR ;
Maertens, JA ;
Baden, LR ;
Dmoszynska, A ;
Cornely, OA ;
Bourque, MR ;
Lupinacci, RJ ;
Sable, CA ;
dePauw, BE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1391-1402
[18]   Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. [J].
Walsh, TJ ;
Pappas, P ;
Winston, DJ ;
Lazarus, HM ;
Petersen, F ;
Raffalli, J ;
Yanovich, S ;
Stiff, P ;
Greenberg, R ;
Donowitz, G ;
Lee, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :225-234
[19]   The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting [J].
White, PL ;
Linton, CJ ;
Perry, MD ;
Johnson, EM ;
Barnes, RA .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (04) :479-486